Bai, Z.; Li, C.; Lai, Y.; Hu, X.; Shi, L.; Guan, X.; Xu, Y.
Role of Rifaximin in the Prognosis of Critically Ill Patients with Liver Cirrhosis. Antibiotics 2025, 14, 287.
https://doi.org/10.3390/antibiotics14030287
AMA Style
Bai Z, Li C, Lai Y, Hu X, Shi L, Guan X, Xu Y.
Role of Rifaximin in the Prognosis of Critically Ill Patients with Liver Cirrhosis. Antibiotics. 2025; 14(3):287.
https://doi.org/10.3390/antibiotics14030287
Chicago/Turabian Style
Bai, Zhaohui, Congcong Li, Yongjie Lai, Xiaojuan Hu, Luwen Shi, Xiaodong Guan, and Yang Xu.
2025. "Role of Rifaximin in the Prognosis of Critically Ill Patients with Liver Cirrhosis" Antibiotics 14, no. 3: 287.
https://doi.org/10.3390/antibiotics14030287
APA Style
Bai, Z., Li, C., Lai, Y., Hu, X., Shi, L., Guan, X., & Xu, Y.
(2025). Role of Rifaximin in the Prognosis of Critically Ill Patients with Liver Cirrhosis. Antibiotics, 14(3), 287.
https://doi.org/10.3390/antibiotics14030287